Invesco’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121M | Buy |
2,801,065
+594,902
| +27% | +$25.7M | 0.02% | 775 |
|
|
2025
Q1 | $76.3M | Buy |
2,206,163
+1,313,036
| +147% | +$45.4M | 0.01% | 876 |
|
|
2024
Q4 | $24.5M | Buy |
893,127
+35,670
| +4% | +$979K | ﹤0.01% | 1385 |
|
|
2024
Q3 | $21.8M | Sell |
857,457
-231,263
| -21% | -$5.89M | ﹤0.01% | 1428 |
|
|
2024
Q2 | $27.6M | Buy |
1,088,720
+90,095
| +9% | +$2.28M | 0.01% | 1277 |
|
|
2024
Q1 | $30.9M | Sell |
998,625
-273,911
| -22% | -$8.47M | 0.01% | 1242 |
|
|
2023
Q4 | $51.4M | Buy |
1,272,536
+112,383
| +10% | +$4.54M | 0.01% | 992 |
|
|
2023
Q3 | $30.6M | Buy |
1,160,153
+475,684
| +69% | +$12.5M | 0.01% | 1157 |
|
|
2023
Q2 | $11.8M | Buy |
684,469
+631,161
| +1,184% | +$10.9M | ﹤0.01% | 1695 |
|
|
2023
Q1 | $884K | Buy |
53,308
+10,681
| +25% | +$177K | ﹤0.01% | 2940 |
|
|
2022
Q4 | $325K | Sell |
42,627
-276,255
| -87% | -$2.11M | ﹤0.01% | 3457 |
|
|
2022
Q3 | $3.17M | Buy |
318,882
+275,673
| +638% | +$2.74M | ﹤0.01% | 2432 |
|
|
2022
Q2 | $392K | Sell |
43,209
-981
| -2% | -$8.9K | ﹤0.01% | 3424 |
|
|
2022
Q1 | $449K | Sell |
44,190
-3,649
| -8% | -$37.1K | ﹤0.01% | 3414 |
|
|
2021
Q4 | $798K | Sell |
47,839
-5,027
| -10% | -$83.9K | ﹤0.01% | 3154 |
|
|
2021
Q3 | $2.48M | Buy |
52,866
+6,207
| +13% | +$291K | ﹤0.01% | 2703 |
|
|
2021
Q2 | $2.85M | Buy |
46,659
+22,185
| +91% | +$1.35M | ﹤0.01% | 2679 |
|
|
2021
Q1 | $1.51M | Sell |
24,474
-12,058
| -33% | -$742K | ﹤0.01% | 2873 |
|
|
2020
Q4 | $2.6M | Buy |
36,532
+30,631
| +519% | +$2.18M | ﹤0.01% | 2504 |
|
|
2020
Q3 | $222K | Buy |
+5,901
| New | +$222K | ﹤0.01% | 3396 |
|
|
2020
Q2 | – | Sell |
-9,792
| Closed | -$284K | – | 3602 |
|
|
2020
Q1 | $284K | Buy |
9,792
+2,941
| +43% | +$85.3K | ﹤0.01% | 3260 |
|
|
2019
Q4 | $240K | Buy |
+6,851
| New | +$240K | ﹤0.01% | 3444 |
|